Roche Diagnostics: Company Profile
Roche Diagnostics: Company Profile examines the Swiss global research-based healthcare company. With product sales almost twice that of its nearest competition, Roche is the world’s largest supplier of clinical diagnostics products. Roche is as well the global world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Roche is also the world’s largest biotech company, with 14 biopharmaceuticals on the market. Further, Roche’s personalized healthcare strategy aims at providing medicines and diagnostic tools for patient disease management.
Roche’s products support clinical decision making in a wide variety of indication fields, including oncology, virology, cardiovascular, inflammatory and infectious diseases. Roche Professional Diagnostics provides solutions for blood serum testing in central laboratories such as commercial and hospital labs.
Roche also participates in many other markets, including:
- Personalized Medicine
- Liquid Biopsy
- Next-Generation Sequencing
- Point of Care (POC) Molecular Testing
Ventana Medical Systems, acquired in 2008, and Genentech, acquired in 2009, both members of the Roche Group, are briefly profiled.
Roche has been active in 2015. Recent developments are discussed.
The information presented in this report is the result of data gathered from government reports, company product literature and other corporate brochures and documents, as well as information found in the scientific and trade press.